Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - enrofloxacin - solution for injection - 50 mg/ml - bovine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - enrofloxacin - tablets - 150 mg/tablet - enrofloxacin - canine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - enrofloxacin - tablets - 50 mg/tablet - enrofloxacin - canine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

virbac s.a. - enrofloxacin - solution for injection - 50 mg/ml - antibacterial - bovine canine feline porcine

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - enrofloxacin - tablet - 50 mg/tablet - enrofloxacin - dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

vetpharma animal health, s.l. - enrofloxacin - oral solution - 5 milligram(s)/millilitre - enrofloxacin - pigs - antibacterial

United States - English - NLM (National Library of Medicine)

bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg - baytril® (brand of enrofloxacin) antibacterial tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. baytril antibacterial tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

United States - English - NLM (National Library of Medicine)

bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg - baytril® (brand of enrofloxacin)taste tabs® antibacterial tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. baytril antibacterial tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or gia

United States - English - NLM (National Library of Medicine)

yicheng chemical corp. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 1 kg in 1 kg

United States - English - NLM (National Library of Medicine)

darmerica - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 1 kg in 1 kg